PBC-AIH overlap syndrome with concomitant ITP and Hashimoto’s disease with positivity for anti-centromere antibody

Arakawa, Yasuo; Amaki, Shuichi; Miyakawa, Hiroshi; Sakai, Toshimitsu; Gotou, Iori; Tanaka, Naohide; Moriyama, Mitsuhiko; Iwasaki, Ariyoshi; Sugitani, Masahiko; Arakawa, Yasuyuki
May 2004
Journal of Gastroenterology;2004, Vol. 39 Issue 5, p490
Academic Journal
We report a case of primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome with concurrent idiopathic thrombocytopenic purpura (ITP) and Hashimoto’s disease with positivity for anticentromere antibody. The patient was a 64-year-old woman with symptoms of jaundice and general fatigue. About 30 years earlier, she had been diagnosed as having ITP and had undergone splenectomy. As part of her present history, she had exhibited liver dysfunction in 1995, during the follow-up of Hashimoto’s disease, and a liver biopsy led to the diagnosis of PBC. In March 2000, she was admitted to hospital because of general fatigue and jaundice. Blood tests revealed: total protein (TP), 6.6 g/dl; γ-globulin (glb), 35.9%; total bilirubin (T-bil), 9.41 mg/dl; direct bilirubin (D-bil), 7.52 mg/dl; aspartate aminotransferase (AST), 957 U/l; alanine aminotransferase (ALT), 651 U/l; alkaline phosphatase (ALP), 595 U/l; γ-guanosine triphosphate (GTP), 129 U/l; IgG, 2620 mg/dl; IgM, 223 mg/dl; hepatitis B surface antigen (HBsAg), negative; anti-hepatitis C virus (HCV), negative; antinuclear antibody, positive; antimitchondrial antibody (AMA), negative (by the immunofluorescence [IF] method); and anti-pyruvate dehydrogenase complex (PDC)-E2 antibody, positive (by Western blotting). Anticentromere antibody (ACA), which is an alternative diagnostic marker for PBC, was detected in this patient. Prednisolone was administered after admission and liver function test results improved markedly. The liver biopsy in 1995 had revealed infiltration of lymphocytes and plasma cells in the portal areas with fibrous expansion and periportal necrosis. Destructive cholangitis was observed, as well as scattered epitheloid cell granulomas in some portal areas. Liver biopsy after the steroid treatment revealed alleviated necrotic inflammatory responses of hepatocytes, while the destructive cholangitis persisted. This is a very rare case of PBC-AIH overlap syndrome accompanied by ITP and Hashimoto’s disease which provides a possible insight into the mechanisms and interplay of autoimmune diseases.


Related Articles

  • An Assessment of the Role of Liver Biopsies in Asymptomatic Patients With Chronic Liver Test Abnormalities. Sorbi, Darius; McGill, Douglas B.; Thistle, Johnson L.; Therneau, Terry M.; Henry, Jessica; Lindor, Keith D. // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3206 

    OBJECTIVE: The role of liver biopsy in the management of patients with nonspecific chronic liver enzyme abnormalities is not well established. The aim of this study is to determine whether liver histology changes the clinical impression formed before liver biopsy and the preliminary management...

  • Esteatohepatitis no alcohólica. López, Erika Martínez; Rosales, José Alfredo Domínguez; Nazara, Zamira Helena Hernández; Cerda, Arturo Panduro // Investigación en Salud;mar2005 Special, Issue 7, p40 

    In 1980, Ludwing and colleagues described patients who lacked a history of alcohol consumption but had findings on liver biopsy that could not be distinguished from those patients with alcoholic hepatitis. Since then, "nonalcoholic steatohepatitis" (NASH) was coined. Diagnostic criteria for NASH...

  • Peritoneoscopy in Chronic Hepatitis. Mazzacca, G.; Bianco, A. R.; Vecchione, R.; Piai, G.; Capalbo, G.; Budillon, G. // American Journal of Gastroenterology;Sep1980, Vol. 74 Issue 3, p244 

    The course of chronic hepatitis was retrospectively evaluated in 26 patients in whom both peritoneoscopy and liver biopsy were initially performed. At entry all patients were clinically asymptomatic and showed mild or moderate histological and chemical abnormalities, so that none of them needed...

  • Treatment of Posttransfusion Non-A, Non-B Acute and Chronic Hepatitis with Human Fibroblast β-Interferon: A Preliminary Report. Ohnishi, Kunihiko; Nomura, Fumio; Iida, Shinji // American Journal of Gastroenterology;Jun1989, Vol. 84 Issue 6, p596 

    We treated five patients with posttransfusion non-A, non-B chronic active hepatitis and six patients with posttransfusion non-A, non-B acute hepatitis with 3 million units of human fibroblast β-interferon three times weekly for 4 wk. Initiation of interferon therapy was followed by a prompt...


    Describes a case report of a patient with cholecystitis and subacite hepatitis. Results of the patient's physical examination; Drugs given to the patient; Pathological biopsy of the liver of the patient.

  • Chronic Active Hepatitis and Hepatic Failure in the Setting of Idiopathic Hemochromatosis. Stankoski, John A.; Roth A., Joel; Gillin, J. Scott // American Journal of Gastroenterology;Jan1987, Vol. 82 Issue 1, p61 

    We report a case of idiopathic hemochromatosis presenting clinically, biochemically, and histopathologically with features of chronic active hepatitis. Liver biopsy demonstrated excessive iron deposition as well as a striking inflammatory process. Progressive deterioration of hepatic function...

  • Interferon α-2b.  // Reactions Weekly;4/8/2006, Issue 1096, p15 

    Discusses a case involving a 52-year-old man who developed autoimmune hepatitis while receiving interferon α-2b for recurrent hepatitis C virus infection. Antiviral regimen started by the man; Results of his liver biopsy.

  • Autoimmune hepatitis as a part of polyglandular autoimmune syndrome type II: case report and literature review. Patel, Trushar; Nystrom, Jacquelyn; Pyrsopoulos, Nikolaos // Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p861 

    The article presents a case study related to autoimmune hepatitis (AIH). A 48-year-old man was admitted for fatigue, abdominal discomfort, and jaundice. His laboratory analysis was compatible with acute hepatitis. A liver biopsy was performed as the patient's clinical condition continued to...

  • What Has the Optimistic Bias Got to Do with the Need to Differentiate Fatty Liver from Nonalcoholic Steatohepatitis? Tarantino, Giovanni // Journal of Gastrointestinal & Liver Diseases;Sep2011, Vol. 20 Issue 3, p229 

    The author reflects on the optimistic bias of people in differentiating nonalcoholic steatohepatitis (NASH) and fatty liver (NAFLD). He states that social science and neuroscience suggest that people are more optimistic than realistic. He argues about committing past mistakes by hepatologists in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics